Send Love from Near and Far with the Hickory Farms Valentine’s Day Collection

Assortment Features Premium Wines, Charcuterie Sets, Decadent Chocolates and Much More!

CHICAGO, Jan. 14, 2021 (GLOBE NEWSWIRE) — As we approach another holiday made difficult by social distancing, America’s Favorite Food Gift Retailer, Hickory Farms, is unveiling dozens of festive and delicious options in its Valentine’s Day 2021 collection that will certainly help people feel the love.

The new collection, launching today on HickoryFarms.com, includes sweet and savory options in beautifully designed packaging, including their Hot Stuff Summer Sausage & Cheese Gift Box, Premium Charcuterie & Chocolate Gift Box with Wine, Itty Bitty Sweetheart Flight and much more.

“After seeing unprecedented demand throughout 2020, it’s clear that people are craving ways to feel connected to loved ones,” said Diane Pearse, CEO at Hickory Farms. “We’re delighted to unveil our Valentine’s Day collection to help people send love and feel a real connection at a time when it’s needed more than ever.”


Valentine’s Day Gift Ideas from Hickory Farms



  • Hot Stuff Summer Sausage & Cheese Gift Box

    – Give a spicy twist on our best-selling, most loved gourmet gift! This meat and cheese gift box is perfect for your Valentine who loves snacks with a kick. They can combine our Signature Beef Summer Sausage and Spicy Beef Summer Sausage with a selection of Smoked Gouda Blend, Jalapeño Cheddar Blend, and Smoked Cheddar Blend cheeses. Along with Spicy Sriracha and Sweet Hot Mustards, these tasty bites are ready to dip and delight. The signature designed Valentine’s Day box adds a fun touch to this gift. ($49.99)


  • Sweets & Rosé Gift Basket

    – Sweets for your sweetie! This gift basket is filled with decadent chocolates and adorable Valentine’s Day treats. The included bottle of Generosity Cellars California Rosé is the perfect wine to enjoy with these sweets. Surprise your best friend or someone special with this thoughtful gift for Valentine’s Day. ($72.99)


  • Premium Charcuterie & Chocolate Gift Box with Wine

    – Give the gift of the perfect date night in, complete with wine! This premium meat and cheese gift box lets recipients create savory flavor combinations with Signature Beef and Sweet & Smoky Turkey Summer Sausages, Original Dry Salami, Smooth & Sharp Cheddar Blend, Mission Jack Blend, Smoked Gouda Blend, Hot Pepper Bacon Jam, Smoky Onion Mustard, and Cranberry Pistachio Crisps. Cranberry & Sesame Nut Mix is the perfect addition to their meat and cheese spread, and Dark Chocolate Peanut Butter Meltaways and Dark Chocolate Sea Salt Caramels make this gift extra indulgent. They can be enjoyed with a glass of Generosity Cellars California Cabernet Sauvignon for an elevated flavor experience! ($89.99)


  • Veuve Clicquot Rosé Champagne Gift Basket

    – Make every celebration really pop! This champagne gift basket is the perfect way to impress. Veuve Clicquot Brut Rosé Champagne is deliciously paired with decadent sweets and snacks like Dark Chocolate Sea Salt Caramels, a box of Tasty Treats that contains either dried fruit, nuts, or candies sourced from California. Marich Dark & White Chocolate Strawberries from California’s Central Coast, Sea Salt Pistachios, and a Salted Caramel Dreaming Bar from Southern California’s Chuao Chocolatier. ($159)


  • Valentine’s Day Chocolate Covered Strawberries

    – Chocolate covered strawberries are a classic treat to show someone you care. We’ve taken our mouthwatering strawberries and covered them in luscious Belgian chocolate, then dressed them up for Valentine’s Day with festive sprinkles and colored accents. This delicious gift comes with four milk chocolate and two dark chocolate strawberries so you don’t have to choose. Treat your sweetie — or yourself — to these indulgent treats. ($29.99)


  • Valentine’s Day Sweet & Savory Gift Tower

    – This Valentine’s Day gift is a stack of signature-designed boxes filled with treats they’ll love. Signature Beef Summer Sausage, Smooth & Sharp Cheddar Blend, and Belgian Ale Mustard pair perfectly to create savory bites. Heart Pretzels, Milk Chocolate Covered Sandwich Cookies, and Cherry Sours add sweetness to this gift. Send as a special way to celebrate with your favorite snack lover. ($42.99)
  • Much more here!

This month and next, Hickory Farms will be offering special promotions such as free shipping and more. Make sure to follow on Instagram, Facebook and Twitter for the latest news.

*All alcohol gifts have shipping restrictions. Generosity Cellars, Aunar, and Contollo wines are shippable to all but the following states: AK, AL, AR, DE, HI, KY, MS, RI, SD, UT. Brand name wines and champagne are available to ship to CA, FL, MN, and DC. Find out more at www.hickoryfarms.com

ABOUT HICKORY FARMS, LLC

Since 1951, Hickory Farms LLC has been a leading retailer of food gifts and specialty foods available online, in catalogs, and in leading mass merchants, supermarkets, and a variety of seasonal retail shopping locations in the U.S. and Canada. For more information, visit www.HickoryFarms.com or join the conversation on Instagram; Facebook; Pinterest; or Twitter.

Media Contacts:

Diana Davis
Hickory Farms
Email: [email protected]
Tel: 312.361.3469

Jeannie Evanchan
Praytell Agency
Email: [email protected]
Tel: 317.385.5752

Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/cb3273ef-84ca-4ef5-9781-7a8bcb045a32

https://www.globenewswire.com/NewsRoom/AttachmentNg/97318027-99a0-44cc-a25c-d4681882864f



Marsh & McLennan Announces Carbon Reduction Commitments

Marsh & McLennan Announces Carbon Reduction Commitments

NEW YORK–(BUSINESS WIRE)–
Marsh & McLennan (NYSE: MMC), the world’s leading expert in risk, strategy and people, today announced two important commitments in the effort to combat climate change. First, the Company has pledged to be carbon neutral in 2021 through the reduction of greenhouse gas emissions in its own operations and the purchase of verifiable offsets. Second, the Company has committed to reduce its carbon emissions by 15% below 2019 levels by the year 2025. The specifics of these commitments will be set out in greater detail in the company’s upcoming 2020 ESG report in March.

“At Marsh & McLennan, we recognize the opportunity, and indeed the obligation, that we have to be good stewards of the environment. We are committed to the principle of responsible capitalism. These climate initiatives represent a tangible step toward building a more sustainable environment for our colleagues, clients, shareholders and future generations,” said Dan Glaser, President and CEO, Marsh & McLennan.

These commitments also complement important climate work that is occurring across the company. In 2020, Marsh’s Global Power & Energy Group launched the first integrated global renewable industry practice in insurance broking. Marsh is also helping clients measure and manage the risks to their assets and operations from hurricanes, floods and other natural perils in a changing climate.

Oliver Wyman’s climate and sustainability experts work with clients across a range of sectors such as financial services, energy and transportation, to reimagine end-to-end supply chains, de-carbonize business models, and integrate new technologies to support the transition to a low carbon economy.

Mercer was recently ranked the No. 1 responsible investment consultant and has led the way in quantifying climate risks in investment portfolios for institutional clients. Mercer also provides climate analytics and advice for institutional investors who want to transition to a 1.5°C scenario of global warming as outlined in the Paris Agreement.

Guy Carpenter helps insurers quantify the impact of natural catastrophe risk and respond to new regulatory climate stress tests. As the frequency and severity of natural catastrophes increase, Guy Carpenter’s experts work with clients to anticipate and mitigate climate threats in particularly high-risk areas.

About Marsh & McLennan Companies

Marsh & McLennan (NYSE: MMC) is the world’s leading professional services firm in the areas of risk, strategy and people. The Company’s 76,000 colleagues advise clients in over 130 countries. With annual revenue of $17 billion, Marsh & McLennan helps clients navigate an increasingly dynamic and complex environment through four market-leading businesses. Marsh advises individual and commercial clients of all sizes on insurance broking and innovative risk management solutions. Guy Carpenter develops advanced risk, reinsurance and capital strategies that help clients grow profitably and pursue emerging opportunities. Mercer delivers advice and solutions to help organizations reshape work, retirement, investment and health outcomes for a changing workforce. Oliver Wyman serves as a critical strategic, economic and brand advisor to private sector and governmental clients. For more information, visit mmc.com, follow us on LinkedIn and Twitter or subscribe to BRINK.

Media:

Erick Gustafson

Marsh & McLennan

+1 202 263 7788

[email protected]

Investors:

Sarah DeWitt

Marsh & McLennan

+1 212 345 6750

[email protected]

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Professional Services Insurance Human Resources Finance Consulting Banking Accounting

MEDIA:

Logo
Logo

Empire Life Investments Acquires Shares of CES Energy Solutions Corp

TORONTO, Jan. 14, 2021 (GLOBE NEWSWIRE) — Empire Life Investments Inc. (“ELII”) announced that it has filed an early warning report with respect to the acquisition of common shares of CES Energy Solutions Corp. (the “Issuer”) held by certain funds managed by ELII. This press release is being filed to report certain acquisitions made by ELII through the facilities of the Toronto Stock Exchange.

ELII is an investment manager as defined in National Instrument 62-103 in relation to securities over which it exercises discretion to vote, acquire or dispose without the express consent of the beneficial owner, subject to applicable legal requirements, general investment policies, guidelines, objectives or restrictions.

ELII exercises control or direction, but not direct ownership, over certain common shares of the Issuer held by various funds managed by ELII. As of the date hereof, ELII exercises control or direction over 26,554,694 common shares of the Issuer, representing approximately 10.20% of the 260,271,215 common shares issued and outstanding.

A copy of the early warning report will appear on SEDAR at sedar.com and may be obtained upon request from Empire Life Investments at 165 University Avenue, 9th Floor, Toronto, ON M5H 3B8.

About Empire Life Investments Inc.

Empire Life Investments Inc. (ELII) is a wholly-owned subsidiary of The Empire Life Insurance Company. The company manages and offers mutual funds and is the portfolio manager of the Empire Life segregated funds. Follow Empire Life Investments Inc. on Twitter @EmpireLifeInv or visit www.empirelifeinvestments.ca for more information.

Commissions, trailing commissions, management fees and expenses all may be associated with investment funds. Please read the prospectus before investing. Mutual funds are not guaranteed and past performance may not be repeated. This communication is not to be construed as a public offering to sell, or a solicitation of an offer to buy securities. Such an offer can only be made by way of a prospectus or other applicable offering document and should be read carefully before making any investment. This release is for information purposes only. Investors should consult their financial advisor for details and risk factors regarding specific strategies and various investment products.

Contact: Julie Tompkins, VP Corporate Services and Chief Communications Officer, 613-548-1890, x3301, [email protected]



Access-Power & Co., Inc. is pleased to announce a bright outlook for 2021

GRAND HAVEN, Mich., Jan. 14, 2021 (GLOBE NEWSWIRE) — Access-Power & Co., Inc., (“ACCR or the Company”), a Grand Haven based diversified holding Company is pleased to announce we have incorporated and integrated all of our non-tangible assets to the balance sheet. “We have a value that needs to be injected into our balance sheets. We must be careful in the preparation of our financial statements. We are in our final stages of preparation for the submission of documents to OTC Markets,” commented Patrick J Jensen, the sold Director of ACCR. We must be precise and accurate in our submission of documents when we apply to the PINK CURRENT INFORMATION tier soon at OTC Markets.

Again, Patrick J Jensen has guaranteed all monthly expenses the Company for 2021.

“2021 will bring us a new beginning. Onto another topic, the Company recently received 3 requests in the last 24 hours, to buy out all of the Company shares,” Patrick J Jensen exclaimed. “I told all parties NO. They see our Company market capitalization rising and NOW want in….I am currently working with our consultant. We are so pleased with our consultant. How this all evolved was a gift from GOD. Our consultant already serves with other publicly traded companies, and he is AWESOME. My new partner advised he has an idea on a Company to merge into ACCR once we go PINK CURRENT INFORMATION.”

There is risk everywhere, however, our Director Patrick stated, “My Dear Shareholders deserve the BEST, and only deserve the very BEST! With a reverse merger to bring in a really big Company that generates income. We plan to audit the incoming private Company, and then integrate its equity into ACCR.” In all Patrick stated, “We only have substantially less than 90,000,000 in our direct FLOAT. This represents a market capitalization of about $500,000 based on current valuation levels.” Patrick owns 186,984,379 total shares of the Company, and will not dilute our Shareholders today, PERIOD.

CLONES BY DRONES and CLONES BY CARS are worth millions to our Director. These are 100% legal business models and inventions and they are incredible. However, our consultant will be very careful in the integration of our intangible assets. He advised that we need proper valuation integrated into the balance sheet. We seek a legal advisor.

Patrick our sole Director since March 2012 rejoiced, “A reverse merger or merger is my goal for 2021. We have a clean share structure. I plan to do this the right way. Use company equity in a very responsible way, a little at a time, whenever needed for our growth strategies. ACCR has strong management disciplinary skills to handle this. In the end, all of my dear Shareholders deserve this done the right way.”

Established in 1996, Access-Power, Inc. is a Florida based for-profit Corporation with operations in West Michigan.

There are various risk factors that should be carefully considered in evaluating our business; because such factors may have a significant impact on our business, our operating results, our liquidity and financial condition. As a result of these various risk factors, actual results could differ materially from those projected in any forward-looking statements. Additional risks and uncertainties not presently known to us, or that we currently consider to be immaterial, may also impact our business, result of operations, liquidity and financial condition. If any such risks occur, our business, its operating results, liquidity and financial condition could be materially affected in an adverse manner. Under such circumstances, if a stable trading market for our securities is established, the trading price of our securities could decline, and you may lose all or part of your investment.

SECURITIES ISSUED BY THE COMPANY INVOLVE A HIGH DEGREE OF RISK AND, THEREFORE, SHOULD BE CONSIDERED EXTREMELY SPECULATIVE. THEY SHOULD NOT BE PURCHASED BY PERSONS WHO CANNOT AFFORD THE POSSIBILITY OF THE LOSS OF THE ENTIRE INVESTMENT. PROSPECTIVE INVESTORS SHOULD READ ALL OF THE COMPANY’S FILINGS, INCLUDING ALL EXHIBITS, AND CAREFULLY CONSIDER, AMONG OTHER FACTORS THE VARIOUS RISK FACTORS THAT MAY BE PRESENT.

BEWARE OF NAKED SHORTING IN OUR COMMON SHARES

You should be aware that there are many substantial risks to an investment in our common stock. Carefully consider these risk factors, along with any available information currently reported by the Company (of which there are note), before you decide to invest in shares of our common stock.   If these risk factors were to occur, our business, financial condition, results of operations or future prospects could be materially adversely affected. If that happens, the market price for our common stock, if any, could decline, and prospective investors would likely lose all or even part of their investment.

Cautionary Language Concerning Forward-Looking Statements

Statements in this press release may be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “anticipate”, “believe”, “estimate”, “expect”, “intend”, and similar expressions, as they relate to the Company or its management, identify forward-looking statements. These statements are based on current expectations, estimates, and projections about the Company’s business, based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors.

Contact Information:

Patrick J. Jensen
Director
Tel:  616.312.5390
Email:  [email protected]
Corporate Website:  http://www.myaccess-power.com

“Our corporate website is currently under construction to soon reflect our new business model in the Michigan Medical Marijuana Clone sector.”

Product Website
http://www.mycbdpets.com

http://www.clonesbydrones.com

https://www.hempster19.com


http://www.clonesbycars.com

Access-Power & Co., Inc. 
OTC Ticker:  ACCR



INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Belden Inc. and Encourages Investors with Losses to Contact the Firm

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Belden Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Belden Inc. (“Belden” or “the Company”) (NYSE: BDC) for potential breaches of fiduciary duty on the part of its directors and management.

If you are a shareholder, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

The Schall Law Firm

Brian Schall, Esq.

310-301-3335

[email protected]

www.schallfirm.com

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

Logo
Logo

New Data at the 2021 ASTS Winter Symposium to Showcase Benefit of Serial Prospera™ Testing

PR Newswire

SAN CARLOS, Calif., Jan. 14, 2021 /PRNewswire/ — Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA (cfDNA) testing, today announced it will present new data on the Prospera test at the American Society of Transplant Surgeons (ASTS) 21st Annual Winter Symposium, taking place January 14-16, 2021.

Natera will present five posters, featuring case studies that detail the use of the Prospera test to detect active rejection and injury of kidney transplants.

“Donor-derived cfDNA testing is becoming an increasingly powerful tool to better assess kidney transplant rejection, and I’m delighted to collaborate with Natera, who is at the forefront of this research,” said Dr. Obi Ekwenna, MD, FACS, Transplant Surgeon at the University of Toledo Medical Center, and first author of two of the studies to be presented. “In our studies, we show that serial testing with the Prospera test provides valuable information about allograft health, and enables transplant providers and nephrologists to better manage patients and reduce the risk of graft failure.”

Details about the abstracts are as follows:

Abstract # 2020-A-151-ASTS | Poster Presentation

Presenter: Obi Ekwenna, MD, FACS

Elevated donor-derived cell-free DNA in patients with delayed graft function

We present a retrospective study of Prospera test results in 16 kidney transplant recipients who developed delayed graft function (DGF). 56.2% of them had elevated donor-derived cfDNA (dd-cfDNA) levels at the first blood draw following transplant with a mean dd-cfDNA of 1.32%. Persistently elevated dd-cfDNA levels were associated with prolonged DGF, while decreasing levels were associated with resolution of DGF, suggesting that dd-cfDNA dynamics over time can potentially serve as a predictive marker for resolution of DGF.

Abstract # 2020-A-135-ASTS | Poster Presentation

Presenter: Obi Ekwenna, MD, FACS

Serial testing with donor-derived cell-free DNA test to monitor dual and en bloc kidney transplants for active rejection

This is a case series of nine patients who have undergone dual or en bloc kidney transplants. In both of these clinical scenarios, increased allograft volume or other factors not yet defined may contribute to increased basal levels of dd-cfDNA. This study demonstrates the utility of serial monitoring with the Prospera test, starting early in the clinical course of the recipient, to better surveil renal allografts.

Abstract # 2020-A-52-ASTS | Poster Presentation

Presenter: Mark Fajardo, MHA, BSN, RN

Assessment of donor-derived cell-free DNA for allograft rejection in kidney transplant patients and its incorporation into clinical practice

This abstract is a real-world clinical experience study describing the use of the Prospera test in more than 1,000 kidney transplant recipients. Renal allograft biopsies performed within two weeks of a positive Prospera test result showed active rejection 64.3% of the time, which is a considerably higher rate than is seen with other rejection biomarkers and superior to what is described in previously published validation studies in patient populations at average risk of rejection, indicating that physicians are using dd-cfDNA to make better decisions around biopsy.

Abstract # 2020-A-142-ASTS | Poster Presentation

Presenter: David Ono, MD

Clinical utility of donor-derived cell-free DNA testing for allograft rejection in patients with limited access to biopsy

We present a retrospective analysis of four cases where serial dd-cfDNA testing was used to remotely monitor kidney transplant rejection as an alternative to biopsy. In all cases, dd-cfDNA levels were consistent with biopsy results or physician assessment of rejection status, highlighting the clinical utility of the Prospera test in patients with limited access to biopsy.

Abstract # 2020-A-131-ASTS | Poster Presentation

Presenter: Prince Mohan, MD

Anti-rejection therapies in renal transplant patients may influence background cell-free DNA, impacting the quantification of donor-derived cell-free DNA

This is a case study of a kidney transplant recipient who was serially monitored with the Prospera test while on anti-rejection therapy. The patient had a sudden decrease in dd-cfDNA levels, with a simultaneous increase in host-derived background cfDNA, which coincided with administration of anti-rejection therapy. These data suggest the patient’s immunosuppressive therapy may influence the dd-cfDNA fraction and potentially impact dd-cfDNA results, thus highlighting the importance of longitudinal monitoring with independent assessment of dd-cfDNA and background cfDNA.

In addition to the poster presentations, Natera will be sponsoring a number of virtual sessions with several key transplant leaders. For more information, visit: natera.com/organ-health/asts-2021.

About the Prospera Test
The Prospera test leverages Natera’s core single-nucleotide (SNP)-based massively multiplexed PCR (mmPCR) technology to identify allograft rejection non-invasively and with high precision and accuracy, without the need for prior donor or recipient genotyping. The test works by measuring the fraction of donor-derived cell-free DNA (dd-cfDNA) in the recipient’s blood. It may be used by physicians considering the diagnosis of active rejection, helping to rule in or out this condition when evaluating the need for diagnostic testing or the results of an invasive biopsy. The Prospera test has been clinically and analytically validated for performance regardless of donor relatedness, rejection type, and clinical presentation. The Prospera test has been developed and its performance characteristics determined by Natera, the CLIA-certified laboratory performing the test. The test has not been cleared or approved by the US Food and Drug Administration (FDA). CAP accredited, ISO 13485 certified, and CLIA certified.

About Natera


Natera
 is a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a focus on women’s health, oncology, and organ health. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California and Austin, Texas. It offers proprietary genetic testing services to inform obstetricians, transplant physicians, oncologists, and cancer researchers, including biopharmaceutical companies, and genetic laboratories through its cloud-based software platform. For more information, visit natera.com. Follow Natera on LinkedIn.

Forward-Looking Statements
All statements other than statements of historical facts contained in this press release are forward-looking statements and are not a representation that Natera’s plans, estimates, or expectations will be achieved. These forward-looking statements represent Natera’s expectations as of the date of this press release, and Natera disclaims any obligation to update the forward-looking statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially, including with respect to our efforts to develop and commercialize new product offerings, our ability to successfully increase demand for and grow revenues for our product offerings, whether the results of clinical or other studies will support the use of our product offerings, our expectations of the reliability, accuracy and performance of our screening tests, or of the benefits of our screening tests and product offerings to patients, providers and payers. Additional risks and uncertainties are discussed in greater detail in “Risk Factors” in Natera’s recent filings on Forms 10-K and 10-Q and in other filings Natera makes with the SEC from time to time. These documents are available at www.natera.com/investors and www.sec.gov.

Contacts
Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-826-2350
Media: Paul Greenland, VP of Corporate Marketing, Natera, Inc., [email protected]

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/new-data-at-the-2021-asts-winter-symposium-to-showcase-benefit-of-serial-prospera-testing-301208625.html

SOURCE Natera, Inc.

Tauriga Sciences Inc. Completes Payment for the Entirety of its Initial Production Run of its Caffeine Infused Version of Tauri-Gum

This Caffeine Version of Tauri-Gum™ is the 7th  SKU of this Fast-Growing Product Line 

NEW YORK, NY, Jan. 14, 2021 (GLOBE NEWSWIRE) —  via NewMediaWire— Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as an ongoing Pharmaceutical Development initiative, has today announced that it has completed payment for the entirety of its initial production run of its caffeine infused version of Tauri-Gum™. After extensive research, the Company has decided to infuse each piece chewing gum with 50mg of caffeine.  This product will be manufactured in the flavor of CHERRY LIME RICKEY and the MSRP, per Blister Pack, is expected to be set at $9.99 each.  The Company expects that this initial production run will yield approximately 9,000 Blister Packs (900 Retail Display Boxes).  Availability:  This caffeine infused version of Tauri-Gum™ will be available on the Company E-Commerce website (www.taurigum.com), later this Quarter.    

The Company believes that the completed production run of this 7th  SKU of Tauri-Gum™, has the potential to drive additional revenue growth.  In addition to E-Commerce business, the Company will now have 2 distinct Tauri-Gum™ SKUs (which contain no Cannabinoids) – to present to major retailers.  Additionally, with air travel being substantially reduced, a high-quality Caffeine chewing gum may be of interest to those driving extended distances.

In other news, the Company continues to realize important levels of progress with respect to a number of different corporate initiatives.  The Company expects to disclose to shareholders one or more material Agreement(s) / Partnership(s), within the near term.

ABOUT TAURIGA SCIENCES INC.

Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives.  The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market segment.  The main product line, branded as Tauri-Gum™, consists of a proprietary supplement chewing gum that is Kosher certified, Halal certified, and Vegan Formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant) & (Vitamin C + Zinc “Immune Booster” Flavor: Pear Bellini).  The Company’s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website: www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at http://www.tauriga.com

Complementary to the Company’s retail business, is its ongoing Pharmaceutical Development initiative.  This relates to the development of a proposed Pharmaceutical grade version of Tauri-Gum™, for nausea regulation (specifically designed for the following indication: Patients Subjected to Ongoing Chemotherapy Treatment). On March 18, 2020, the Company announced that it had filed a provisional U.S. patent application covering its pharmaceutical grade version of Tauri-Gum™.  The Patent, filed with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”.  On December 18, 2020 the Company disclosed that it had entered into a Master Services Agreement with CSTI to lead the Company’s clinical development efforts.

On October 6, 2020, the Company announced that it has been approved to operate as a U.S. Government Vendor (CAGE CODE # 8QXV4)

The Company is headquartered in Wappingers Falls, New York.  In addition, the Company operates a full time E-Commerce fulfillment center located in LaGrangeville, New York.

DISCLAIMER — Forward-Looking Statements

This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in  forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.

Contact:

Tauriga Sciences, Inc.

4 Nancy Court, Suite 4

Wappingers Falls, NY 12590

Chief Executive Officer

Mr. Seth M. Shaw

Email: [email protected]

cell # (917) 796 9926

Company Instagram: @taurigum

Personal Instagram: @sethsms47

Twitter: @SethMShaw

Corp. Website:   www.tauriga.com

E-Commerce Website:  www.taurigum.com

Attachment



Heficed Announces IPXO, The World’s First Accessible IP Marketplace

Company is innovating rapidly to solve the global IP address shortage as the “New Internet” dawns

LONDON, Jan. 14, 2021 (GLOBE NEWSWIRE) — IPXO, formerly known as Heficed’s IP Address Platform, is now the world’s first accessible IP marketplace. Vincentas Grinius, co-founder and CEO of IPXO, explained, “It is our goal to provide a meaningful solution to help sustain the eco-system of the internet by reintroducing the sleeping inventory of IPv4 addresses into the open market. Additionally, this enables enterprises to capture a significant revenue stream from their unused IP addresses. In this scenario everyone wins as we collaborate to solve the IPv4 shortage until IPv6 is a viable solution for North America.”

IPv4 uses a 32-bit address, allowing for 4.3 billion unique addresses. IPv6 uses a 128-bit address, which provides an immensely higher number of unique address combinations. For some massive global organizations, transitioning from majority IPv4 to majority IPv6 is a great solution. However, it is not a great solution for everyone. Because less than 30% of all internet-connected networks promote IPv6 connectivity, organizations transitioning to IPv6 will have to run IPv4 and IPv6 simultaneously which is both slow and expensive.

Some experts are recommending a shared addresses model where a public IPv4 address is assigned to cover several customers simultaneously. Each customer would have a different port range internally to ensure that there was no overlap. While a good idea conceptually, the technical execution is expensive to build and challenging to maintain. It will likely also lead to slowdowns and more moving parts that can fail.

Neither solution takes into account the millions of dormant IPv4 addresses. Grinius believes, “We don’t need added layers of complexity that will add cost and slowdown transfers of data. What we do need is a way to incentivize ISPs (and other businesses) who are sitting on tens of thousands or hundreds of thousands of unassigned IPv4 addresses to bring those addresses to market for other organizations.” This is where IPXO was conceived. We needed a global platform where IPv4 addresses could be securely leased and monetized, and IPXO is that platform.”

About IPXO

IPXO, formerly known as Heficed’s IP Address Market, is an IP resource management platform, which enables to monetize unused IP addresses via lease. Reportedly having outgrown its current position as part of Heficed’s framework, it will continue to grow and improve as a separate business entity, with the full switch predicted at the beginning of 2021. IPXO will be equipped with advanced features such as reputation monitoring, delegated RPKI, WHOIS, Geo object management, BGP announcement control, and open API.



Media Contact: 
Eric Reed
[email protected]  
(614)896-0874

Altria to Host Webcast of 2020 Fourth-Quarter and Full-Year Results

Altria to Host Webcast of 2020 Fourth-Quarter and Full-Year Results

RICHMOND, Va.–(BUSINESS WIRE)–
Altria Group, Inc. (Altria) (NYSE: MO) will host a live audio webcast on Thursday, January 28, 2021, at 9:00 a.m. Eastern Time to discuss its 2020 fourth-quarter and full-year business results. Altria will issue a press release containing its business results at approximately 7:00 a.m. Eastern Time the same day. The webcast can be accessed at altria.com.

During the webcast, Billy Gifford, Altria’s CEO, and Sal Mancuso, Altria’s CFO, will discuss the Company’s 2020 fourth-quarter and full-year business results and answer questions from the investment community and news media.

The webcast will be in a listen-only mode. Pre-event registration is necessary; directions are posted at www.altria.com/webcasts. An archived copy of the webcast will be available on altria.com.

 

Investor Relations, Altria Client Services

(804) 484-8222

Media Relations, Altria Client Services

(804) 484-8897

Tag: Other Financial

KEYWORDS: Virginia United States North America

INDUSTRY KEYWORDS: Other Professional Services Other Communications Other Retail Wine & Spirits Tobacco Communications Professional Services Retail

MEDIA:

Logo
Logo

Humana Healthy Horizons and The Humana Foundation Commit More Than $2.5 Million to COVID-19 Relief in Texas

Humana Healthy Horizons and The Humana Foundation Commit More Than $2.5 Million to COVID-19 Relief in Texas

AUSTIN, Texas–(BUSINESS WIRE)–
Humana Healthy Horizons, the Medicaid business of Humana Inc. (NYSE: HUM), and Humana’s philanthropic arm, The Humana Foundation, have announced a more than $2.5 million commitment to COVID-19 relief efforts in Texas.

As the COVID-19 pandemic continues to create significant economic and health challenges for people across the U.S., Humana has consistently provided support to both national and local community partners who have experienced a reduction in resources.

Humana Healthy Horizons has contributed a total of more than $1 million to the following community-based organizations in Texas:

Accessible Housing Austin! (AHA!)

This contribution enables the completion of an affordable Austin apartment complex for very low-income individuals with disabilities with the purchase of accessible elevators and appliances, the construction of a community room and an accessible picnic area and more.

YMCA of Metropolitan Dallas Learning Academy

This contribution makes it possible for the YMCA to open multiple new Dallas Summer Learning Academies and to operate the academies in the Spring, if needed, to help bridge the learning gap that traditionally happens when school is out in the summer and that has been made worse by the COVID-19 pandemic.

Communities In Schools of Texas

This contribution to a crisis fund for children in the largest school districts in Dallas, Fort Worth, Houston, San Antonio and Austin provides assistance for rent, utilities, food, clothing and personal hygiene items during the COVID-19 pandemic.

My Health My Resources (MHMR) of Tarrant County

This contribution pays for devices with data plans that are loaned to individuals or caregivers so that they may safely access telehealth for therapy, case management appointments, doctor visits and other needs during the COVID-19 pandemic.

Bexar County Community Health Collaborative

This contribution provides training and certification with job placement support for additional Community Health Workers who serve hundreds of low income families within Bexar and surrounding counties as part of the collaborative’s Community Hub Model, which identifies and addresses risks in a whole person approach.

“This is an important opportunity to work collaboratively with our Texas community partners at a time when so many organizations and individuals have been seriously impacted by the COVID-19 pandemic,” said John Barger, SVP, and President of Humana Healthy Horizons. “Humana has a long history in Texas and a strong commitment to providing quality care while improving the health of the local communities we serve.”

“Accessible Housing Austin! is extremely grateful to Humana Healthy Horizons for their generous grant to the AHA! at Briarcliff apartment complex,” said Jolene Keene, Executive Director, Accessible Housing Austin! “Each of our 27 housing units will be fully accessible to persons with disabilities. Having amenities like large elevators and accessible laundry facilities allows for further access opportunities so that our tenants can live with independence, dignity, and comfort.”

“Humana’s generous investment will allow us to increase workforce capacity needed to connect more families to any resources they need,” said Elizabeth Lutz, Executive Director, Bexar County Community Health Collaborative. “The Community Health Worker is a trusted member in the communities where they live and work. They bring resources to families through our Pathways Community HUB. The Health Collaborative’s program is the only Pathways Community HUB in Texas and in the Southwest Region of the United States.”

“Research shows that two-thirds of the income-based achievement gap is attributed to summer learning loss. This year, the learning loss due to the COVID pandemic will be an added layer, making our summer program more crucial than ever before,” said Jodi Newman, School Age Services Executive Director, YMCA of Metropolitan Dallas. “Through the gift from Humana Healthy Horizons, the YMCA will be able to expand how many children we serve, ensuring more than 150 kids will get the academic and mental health support they need throughout the summer months.”

In addition to the more than $1 million in new commitments from Humana Healthy Horizons, the Humana Foundation has recently contributed more than $1.5 million in direct COVID relief to Texas community-based organizations, including 17 Feeding America member food banks and contributions to local Volunteers of America organizations.

About Humana Healthy Horizons

In 2020, Humana launched its new Medicaid brand, Humana Healthy Horizons™. With this new brand, we are committed to continue demonstrating our strong ability to manage complex populations and create solutions that lead to a better quality of life for our members. Nationally, we serve Medicaid enrollees through Medicaid Managed Care (MMC), Managed Long Term Services and Supports (MLTSS) programs, Centers for Medicare and Medicaid Services (CMS) Financial Alignment Initiative Dual Demonstrations, MA, D‐SNPs, and PDPs.

Humana has served Medicaid populations continuously for more than two decades and currently manages Medicaid benefits for nearly 800,000 members nationally. We have developed expertise providing care management, care planning, and specialized clinical management for the complex needs of Temporary Assistance for Needy Families (TANF); Children’s Health Insurance Program (CHIP); Medicaid Expansion; aged, blind, or disabled (ABD); and dual eligible populations within a social supports‐based framework. Through these years of experience, we have also developed significant expertise in integrating physical health, behavioral health, pharmacy, and social services and supports for a whole-person centered approach to improve the health and well‐being of our members and the communities we serve.

Humana Healthy Horizons is a Medicaid Product of Humana Health Plan, Inc.

About The Humana Foundation

The Humana Foundation was established in 1981 as the philanthropic arm of Humana Inc., one of the nation’s leading health and well-being companies. Located in Louisville, Ky., the Foundation seeks to co-create communities where leadership, culture, and systems work to improve and sustain positive health outcomes. For more information, visit humanafoundation.org.

Humana and The Humana Foundation are dedicated to Corporate Social Responsibility. Our goal is to ensure that every business decision we make reflects our commitment to improving the health and well-being of our members, our employees, the communities we serve, and our planet.

About Humana

Humana Inc. is committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well-being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large.

To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools – such as in-home care, behavioral health, pharmacy services, data analytics and wellness solutions – combine to produce a simplified experience that makes health care easier to navigate and more effective.

More information regarding Humana is available to investors via the Investor Relations page of the company’s web site at www.humana.com, including copies of:

  • Annual reports to stockholders
  • Securities and Exchange Commission filings
  • Most recent investor conference presentations
  • Quarterly earnings news releases and conference calls
  • Calendar of events
  • Corporate Governance information

 

Lisa Dimond

Humana Corporate Communications

832-330-4702

[email protected]

KEYWORDS: Texas United States North America

INDUSTRY KEYWORDS: Children Professional Services Health Philanthropy General Health Women Men Family Foundation Insurance Consumer

MEDIA:

Logo
Logo